Vera Therapeutics, Inc. (VERA)

SEC filing

Vera Therapeutics, Inc.

VERA · CIK 1831828

4 · Sep 17, 2026 · Director, PRESIDENT AND CEO Fordyce Marshall sold 18.50K Class A Common Stock at $37.00/unit ($684.5K); exercised options for 37K shares

Director, PRESIDENT AND CEO Fordyce Marshall sold 18.50K Class A Common Stock at $37.00/unit ($684.5K); exercised options for 37K shares

Filed: Sep 17, 2026
Period: Sep 15, 2026
Accession: 0001859453-26-000015
Filer: Vera Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09172026_080936.xml

xslF345X06/form4-09172026_080936.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09172026_080936.xml
Open SEC.gov